Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Marco

Showing results (21-30 of 173) with videos related to

Pageof 18
Sort By:
International Journal of Antimicrobial Agents|August 4, 2004
In vitro antagonism between beta-lactam and macrolide in Streptococcus pneumoniae: how important is the antibiotic order?Mar Ortega, Francesc Marco, Alex Soriano, et al.
International Journal of Antimicrobial Agents|June 4, 2014
Detection of extended-spectrum β-lactamase- and/or carbapenemase-producing Enterobacteriaceae directly from positive blood culture using a commercialised microarray techniquePedro Juiz, Mar Solé, Cristina Pitart, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Lack of vancomycin tolerance in Streptococcus pneumoniae strains isolated in Barcelona, Spain, from 1999 to 2001Mar Ortega, Francesc Marco, Alex Soriano, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2009
Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoeaEva Mendez Arancibia, Cristina Pitart, Joaquim Ruiz, et al.
International Journal of Antimicrobial Agents|December 17, 2016
Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosaMarc Xipell, Marta Bodro, Francesc Marco, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2014
Molecular characterization of blaNDM-5 carried on an IncFII plasmid in an Escherichia coli isolate from a nontraveler patient in SpainCristina Pitart, Mar Solé, Ignasi Roca, et al.
Chest|September 12, 2006
Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?Xavier Vallès, Angeles Marcos, Mariona Pinart, et al.
Journal of the American College of Cardiology|November 7, 2015
Neglecting enterococci may lead to a misinterpretation of the consequences of last changes in endocarditis prophylaxis American Heart Association guidelinesJuan M Pericas, Carlos Falces, Asuncion Moreno, et al.
The Journal of Antimicrobial Chemotherapy|April 19, 2008
Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemiaMiguel Marcos, Amaia Iñurrieta, Alex Soriano, et al.
Journal of Global Antimicrobial Resistance|January 26, 2018
Clinical experience with ceftolozane/tazobactam in patients with serious infections due to resistant Pseudomonas aeruginosaMarc Xipell, Sandra Paredes, Leticia Fresco, et al.
Pageof 18

Showing results (21-30 of 173) with videos related to

Sort By:
Pageof 18
International Journal of Antimicrobial Agents|August 4, 2004
In vitro antagonism between beta-lactam and macrolide in Streptococcus pneumoniae: how important is the antibiotic order?Mar Ortega, Francesc Marco, Alex Soriano, et al.
International Journal of Antimicrobial Agents|June 4, 2014
Detection of extended-spectrum β-lactamase- and/or carbapenemase-producing Enterobacteriaceae directly from positive blood culture using a commercialised microarray techniquePedro Juiz, Mar Solé, Cristina Pitart, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Lack of vancomycin tolerance in Streptococcus pneumoniae strains isolated in Barcelona, Spain, from 1999 to 2001Mar Ortega, Francesc Marco, Alex Soriano, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2009
Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoeaEva Mendez Arancibia, Cristina Pitart, Joaquim Ruiz, et al.
International Journal of Antimicrobial Agents|December 17, 2016
Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosaMarc Xipell, Marta Bodro, Francesc Marco, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2014
Molecular characterization of blaNDM-5 carried on an IncFII plasmid in an Escherichia coli isolate from a nontraveler patient in SpainCristina Pitart, Mar Solé, Ignasi Roca, et al.
Chest|September 12, 2006
Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?Xavier Vallès, Angeles Marcos, Mariona Pinart, et al.
Journal of the American College of Cardiology|November 7, 2015
Neglecting enterococci may lead to a misinterpretation of the consequences of last changes in endocarditis prophylaxis American Heart Association guidelinesJuan M Pericas, Carlos Falces, Asuncion Moreno, et al.
The Journal of Antimicrobial Chemotherapy|April 19, 2008
Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemiaMiguel Marcos, Amaia Iñurrieta, Alex Soriano, et al.
Journal of Global Antimicrobial Resistance|January 26, 2018
Clinical experience with ceftolozane/tazobactam in patients with serious infections due to resistant Pseudomonas aeruginosaMarc Xipell, Sandra Paredes, Leticia Fresco, et al.
Pageof 18